Kodiak Sciences Inc.

KOD Nasdaq CIK: 0001468748

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1250 PAGE MILL RD, PALO ALTO, CA, 94304
Mailing Address 1250 PAGE MILL RD, PALO ALTO, CA, 94304
Phone 650-281-0850
Fiscal Year End 1231
EIN 270476525

Financial Overview

FY2025

$194.15M
Total Liabilities
$-3.35
EPS

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
8-K Current report of material events March 31, 2026 View on SEC
8-K Current report of material events March 27, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
5 Annual insider ownership changes February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment December 19, 2025 View on SEC
4 Insider stock transaction report December 19, 2025 View on SEC

Annual Reports

10-K March 31, 2026
  • Development of the proprietary ABC Platform for long-lasting eye disease treatments.
  • Focused pipeline on three primary drug candidates: Tarcocimab tedromer, KSI-501, and KSI-101.
View Analysis

Insider Trading

BUY 1 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.